Abstract
Since late 1950s the main strategies to treat cancer, besides surgery, have been radiotherapy or chemotherapy. These approaches work primarily by damaging proliferating cells at the level of DNA replication or cell division, and inducing apoptotic cell suicide as a secondary response to the damage. In recent years, efforts to improve cancer therapy have focused on the development of more selective, biological mechanism based approaches that can help to overcome tumor resistance as well as minimize toxic side effects. In the present review new strategies and new targets for biological cancer therapy will be discussed. In particular, new angiogenic pathways discovered in melanoma will be discussed in relationship to a more efficient anticancer strategy. In summary, this review tries to identify the most logical targets and the most useful mechanisms of tumor inhibition in light of new knowledge from the basic research including human genome project.
Keywords: apoptosis, angiogenesis, vasculogenic mimicry
Current Drug Targets
Title: Cellular Targets for Anticancer Strategies
Volume: 5 Issue: 4
Author(s): Caterina A.M. La Porta
Affiliation:
Keywords: apoptosis, angiogenesis, vasculogenic mimicry
Abstract: Since late 1950s the main strategies to treat cancer, besides surgery, have been radiotherapy or chemotherapy. These approaches work primarily by damaging proliferating cells at the level of DNA replication or cell division, and inducing apoptotic cell suicide as a secondary response to the damage. In recent years, efforts to improve cancer therapy have focused on the development of more selective, biological mechanism based approaches that can help to overcome tumor resistance as well as minimize toxic side effects. In the present review new strategies and new targets for biological cancer therapy will be discussed. In particular, new angiogenic pathways discovered in melanoma will be discussed in relationship to a more efficient anticancer strategy. In summary, this review tries to identify the most logical targets and the most useful mechanisms of tumor inhibition in light of new knowledge from the basic research including human genome project.
Export Options
About this article
Cite this article as:
La Porta A.M. Caterina, Cellular Targets for Anticancer Strategies, Current Drug Targets 2004; 5 (4) . https://dx.doi.org/10.2174/1389450043345434
DOI https://dx.doi.org/10.2174/1389450043345434 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antibiotics as Inhibitor of Glutathione S-transferase: Biological Evaluation and Molecular Structure Studies
Current Drug Metabolism A hypothesis for the role of RECK in angiogenesis
Current Vascular Pharmacology Vaccination Against Angiogenesis-Associated Antigens: A Novel Cancer Immunotherapy Strategy
Current Molecular Medicine Effects of Tobacco Nicotine-Derived Nitrosamine Ketone (NNK) Exposures on Brain Alcohol Metabolizing Enzyme Activities
Drug Metabolism Letters A Novel Method for Screening of Anti-Cancer Drugs: Availability of Screening in Acidic Medium
Recent Patents on Biomedical Engineering (Discontinued) Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Nanoparticles: Properties and Applications in Cancer Immunotherapy
Current Pharmaceutical Design Carbohydrate-Metal Complexes and their Potential as Anticancer Agents
Current Medicinal Chemistry Genetic and Pharmacogenetic Aspects of Alcohol-Dependence
Current Pharmacogenomics Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)
Current Topics in Medicinal Chemistry Treatment Decisions for Non-Melanoma Skin Cancer (NMSC)
Current Cancer Therapy Reviews NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy
Current Medicinal Chemistry Garlic (<i>Allium sativum</i> L.): Its Chemistry, Nutritional Composition, Toxicity, and Anticancer Properties
Current Topics in Medicinal Chemistry Bioactive Compounds in Some Culinary Aromatic Herbs and Their Effects on Human Health
Mini-Reviews in Medicinal Chemistry The Pro-Survival Function of Akt Kinase can be Overridden or Altered to Contribute to Induction of Apoptosis
Current Cancer Drug Targets Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention
Current Protein & Peptide Science A Curcumin Analog, GO-Y078, Effectively Inhibits Angiogenesis through Actin Disorganization
Anti-Cancer Agents in Medicinal Chemistry Anti-HER2 Cancer Therapy and Cardiotoxicity
Current Pharmaceutical Design Novel Drugs Targeting Microtubules: the Role of Epothilones
Current Pharmaceutical Design